Kayla A Holder

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Respiratory Syndrome Coronavirus

Angiotensin Converting Enzyme

Top Venues

Clinical & translational immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Kayla A Holder, Erin Ding, Diana Kao, Mostafa Shokoohi, Jason Trigg, Robert S Hogg, Jatin Morkar, Michael D Grant, Deborah V Kelly
Progress towards World Health Organization HIV Infection 95-95-95 measures in Newfoundland and Labrador, Canada. PloS one 19 (6) (2024)
Kayla A Holder, Erin Ding, Diana Kao, Mostafa Shokoohi, Jason Trigg, Robert S Hogg, Jatin Morkar, Michael D Grant, Deborah V Kelly
Progress towards World Health Organization HIV Infection 95-95-95 measures in Newfoundland and Labrador, Canada. PloS one 19 (6) (2024)
Kayla A Holder, Danielle P Ings, Kathleen E Fifield, David A Barnes, Keeley A Barnable, Debbie O A Harnum, Rodney S Russell, Michael D Grant
Sequence Matters: Primary COVID-19 Vaccination after Infection Elicits Similar Anti-spike Antibody Levels, but Stronger Antibody Dependent Cell-mediated Cytotoxicity than Breakthrough Infection. Journal of immunology (Baltimore, Md. : 1950) (2024)
Natasha J Norton, Kayla A Holder, Danielle P Ings, Debbie O A Harnum, Rodney S Russell, Michael D Grant
Cellular Immune Responses to SARS-CoV-2 in Exposed Seronegative Individuals. Viruses 15 (4) (2023)
Natasha J Norton, Kayla A Holder, Danielle P Ings, Debbie O A Harnum, Rodney S Russell, Michael D Grant
Cellular Immune Responses to SARS-CoV-2 in Exposed Seronegative Individuals. Viruses 15 (4) (2023)
Natasha J Norton, Kayla A Holder, Danielle P Ings, Debbie O A Harnum, Rodney S Russell, Michael D Grant
Cellular Immune Responses to SARS-CoV-2 in Exposed Seronegative Individuals. Viruses 15 (4) (2023)
Natasha J Norton, Danielle P Ings, Kathleen E Fifield, David A Barnes, Keeley A Barnable, Debbie O A Harnum, Kayla A Holder, Rodney S Russell, Michael D Grant
Characteristics of Vaccine- and Infection-Induced Systemic IgA Anti-SARS-CoV-2 Spike Responses. Vaccines 11 (9) (2023)
Natasha J Norton, Kayla A Holder, Danielle P Ings, Debbie O A Harnum, Rodney S Russell, Michael D Grant
Cellular Immune Responses to SARS-CoV-2 in Exposed Seronegative Individuals. Viruses 15 (4) (2023)
Kayla A Holder, Danielle P Ings, Debbie O A Harnum, Rodney S Russell, Michael D Grant
Moderate to severe SARS-CoV-2 infection primes vaccine-induced immunity more effectively than asymptomatic or mild infection. NPJ vaccines 7 (1) (2022)
Kayla A Holder, Kimberley Burt, Michael D Grant
TIGIT blockade enhances NK cell activity against autologous HIV-1-infected CD4+ T cells. Clinical & translational immunology 10 (10) (2021)